publications-banner
Information about pipeline products
The content contained is subject to congress/journal copyright permissions. No further reproduction is permitted without permission of the copyright owner.
Information about pipeline compounds or investigational uses of compounds does not imply FDA approval for these compounds or uses, nor does it establish the safety or efficacy of these compounds or uses. There is no guarantee that the pipeline compounds or investigational uses will receive FDA approval. Daiichi Sankyo does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling.
PublicationView
T-DXd
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): Primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
Edoxaban
A disposable edoxaban sensor chip using carbon paste electrode grafted with molecularly imprinted polymer
T-DXd
Quantitative evaluation of trastuzumab deruxtecan pharmacokinetics and pharmacodynamics in mouse models of varying degrees of HER2 expression
T-DXd
A real-world study of treatment sequences and second-line clinical outcomes in patients with HER2-positive metastatic breast cancer in US community practice
Dato-DXd
Clinical management, monitoring, and prophylaxis of adverse events of special interest associated with datopotamab deruxtecan
Edoxaban
Incidence and predictors of worsening renal function in edoxaban-treated atrial fibrillation patients within ETNA-AF-Europe registry
R-DXd
Raludotatug deruxtecan, a CDH6-targeting antibody-drug conjugate with a DNA topoisomerase I inhibitor DXd, is efficacious in human ovarian and kidney cancer models
Valemetostat
Mechanisms of action and resistance in histone methylation-targeted therapy
Pexidartinib
Real-world drug utilization and treatment patterns in patients with tenosynovial giant cell tumors in the USA
Edoxaban
Prescribing patterns and outcomes of edoxaban in atrial fibrillation patients from Asia — one-year data from the Global ETNA-AF program